Excellere and GHO Capital sell Biocare Medical to Agilent Technologies, boosting global diagnostics reach.

Excellere Partners and GHO Capital have completed the sale of Biocare Medical, a leader in immunohistochemistry and molecular diagnostics, to Agilent Technologies. Under their ownership, Biocare grew revenue and expanded its molecular diagnostics capabilities. The acquisition aligns two companies with complementary strategies in life sciences, expected to enhance market access, customer support, and innovation. This move positions Biocare for accelerated growth with Agilent's global resources.